INTRODUCTION: Near-infrared spectroscopy (NIRS) is a non-invasive, real-time bedside modality sensitive to changes in cerebral perfusion and oxygenation and is highly sensitive to physiological oscillations at different frequencies. However, the clinical feasibility of NIRS remains limited, partly due to concerns regarding NIRS signal quantification, which relies on mostly arbitrary assumptions on hemoglobin concentrations and tissue layers. In this pilot study comparing stroke patients to healthy controls, we explored the utility of the interhemispheric correlation coefficient (IHCC) during physiological oscillations in detecting asymmetry in hemispheric microvascular hemodynamics. METHODS: Using bi-hemispheric continuous-wave NIRS, 12 patients with hemispheric strokes and 9 controls were measured prospectively. NIRS signal was band-pass filtered to isolate cardiac (0.7-3 Hz) and respiratory (0.15-0.7 Hz) oscillations. IHCCs were calculated in both oscillation frequency bands. Using Fisher's Z-transform for non-Gaussian distributions, the IHCC during cardiac and respiratory oscillations were compared between both groups. RESULTS: Nine patients and nine controls had data of sufficient quality to be included in the analysis. The IHCCs during cardiac and respiratory oscillations were significantly different between patients versus controls (cardiac 0.79 +/- 0.18 vs. 0.94 +/- 0.07, P = 0.025; respiratory 0.24 +/- 0.28 vs. 0.59 +/- 0.3; P = 0.016). CONCLUSIONS: Computing the IHCC during physiological cardiac and respiratory oscillations may be a new NIRS analysis technique to quantify asymmetric microvascular hemodynamics in stroke patients in the neurocritical care unit. It allows each subject to serve as their own control obviating the need for arbitrary assumptions on absolute hemoglobin concentration. Future clinical applications may include rapid identification of patients with ischemic brain injury in the pre-hospital setting. This promising new analysis technique warrants further validation.
INTRODUCTION: Near-infrared spectroscopy (NIRS) is a non-invasive, real-time bedside modality sensitive to changes in cerebral perfusion and oxygenation and is highly sensitive to physiological oscillations at different frequencies. However, the clinical feasibility of NIRS remains limited, partly due to concerns regarding NIRS signal quantification, which relies on mostly arbitrary assumptions on hemoglobin concentrations and tissue layers. In this pilot study comparing strokepatients to healthy controls, we explored the utility of the interhemispheric correlation coefficient (IHCC) during physiological oscillations in detecting asymmetry in hemispheric microvascular hemodynamics. METHODS: Using bi-hemispheric continuous-wave NIRS, 12 patients with hemispheric strokes and 9 controls were measured prospectively. NIRS signal was band-pass filtered to isolate cardiac (0.7-3 Hz) and respiratory (0.15-0.7 Hz) oscillations. IHCCs were calculated in both oscillation frequency bands. Using Fisher's Z-transform for non-Gaussian distributions, the IHCC during cardiac and respiratory oscillations were compared between both groups. RESULTS: Nine patients and nine controls had data of sufficient quality to be included in the analysis. The IHCCs during cardiac and respiratory oscillations were significantly different between patients versus controls (cardiac 0.79 +/- 0.18 vs. 0.94 +/- 0.07, P = 0.025; respiratory 0.24 +/- 0.28 vs. 0.59 +/- 0.3; P = 0.016). CONCLUSIONS: Computing the IHCC during physiological cardiac and respiratory oscillations may be a new NIRS analysis technique to quantify asymmetric microvascular hemodynamics in strokepatients in the neurocritical care unit. It allows each subject to serve as their own control obviating the need for arbitrary assumptions on absolute hemoglobin concentration. Future clinical applications may include rapid identification of patients with ischemic brain injury in the pre-hospital setting. This promising new analysis technique warrants further validation.
Authors: Kalle Kotilahti; Ilkka Nissilä; Minna Huotilainen; Riikka Mäkelä; Nasia Gavrielides; Tommi Noponen; Patrick Björkman; Vineta Fellman; Toivo Katila Journal: Neuroreport Date: 2005-08-22 Impact factor: 1.837
Authors: H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw Journal: N Engl J Med Date: 1991-08-15 Impact factor: 91.245
Authors: Ken M Brady; Jennifer K Lee; Kathleen K Kibler; Piotr Smielewski; Marek Czosnyka; R Blaine Easley; Raymond C Koehler; Donald H Shaffner Journal: Stroke Date: 2007-08-30 Impact factor: 7.914
Authors: Juliette Selb; Meryem A Yücel; Dorte Phillip; Henrik W Schytz; Helle K Iversen; Mark Vangel; Messoud Ashina; David A Boas Journal: J Biomed Opt Date: 2015-05 Impact factor: 3.170
Authors: Juliette Selb; Kuan-Cheng Wu; Jason Sutin; Pei-Yi Ivy Lin; Parisa Farzam; Sophia Bechek; Apeksha Shenoy; Aman B Patel; David A Boas; Maria Angela Franceschini; Eric S Rosenthal Journal: Neurophotonics Date: 2018-11-13 Impact factor: 3.593
Authors: Rodrigo M Forti; Christopher G Favilla; Jeffrey M Cochran; Wesley B Baker; John A Detre; Scott E Kasner; Michael T Mullen; Steven R Messé; W Andrew Kofke; Ramani Balu; David Kung; Bryan A Pukenas; Neda I Sedora-Roman; Robert W Hurst; Omar A Choudhri; Rickson C Mesquita; Arjun G Yodh Journal: J Stroke Cerebrovasc Dis Date: 2019-04-08 Impact factor: 2.136
Authors: Juliette Selb; David A Boas; Suk-Tak Chan; Karleyton C Evans; Erin M Buckley; Stefan A Carp Journal: Neurophotonics Date: 2014-07 Impact factor: 3.593
Authors: Dorte Phillip; Henrik W Schytz; Juliette Selb; Stephen Payne; Helle K Iversen; Lene T Skovgaard; David A Boas; Messoud Ashina Journal: Eur J Clin Invest Date: 2012-08-16 Impact factor: 4.686
Authors: Sabrina Brigadoi; Lisa Ceccherini; Simone Cutini; Fabio Scarpa; Pietro Scatturin; Juliette Selb; Louis Gagnon; David A Boas; Robert J Cooper Journal: Neuroimage Date: 2013-04-29 Impact factor: 6.556